Center for Latin American Caribbean Studies Center for Latin American Caribbean Studies
Arts & Sciences
Duke University

 HOME > Arts & Sciences > CLACS    Search Help Login pdf version printable version 
Webpage

Center for Latin American Caribbean Studies : Publications since January 2018

List all publications in the database.    :chronological  alphabetical  combined  bibtex listing:

Aidoo, Lamonte

  1. Aidoo, L, Slavery Unseen: Sex, Power, and Violence in Brazilian History (Latin America Otherwise) (April, 2018), Duke University Press Book, ISBN 0822371162

Baker, Paul A.

  1. Guédron, S; Tolu, J; Brisset, E; Sabatier, P; Perrot, V; Bouchet, S; Develle, AL; Bindler, R; Cossa, D; Fritz, SC; Baker, PA, Late Holocene volcanic and anthropogenic mercury deposition in the western Central Andes (Lake Chungará, Chile)., The Science of the Total Environment, vol. 662 (April, 2019), pp. 903-914 [doi]  [abs]
  2. Marsh, EJ; Bruno, MC; Fritz, SC; Baker, P; Capriles, JM; Hastorf, CA, IntCal, SHCal, or a Mixed Curve? Choosing a 14 C Calibration Curve for Archaeological and Paleoenvironmental Records from Tropical South America, Radiocarbon, vol. 60 no. 3 (June, 2018), pp. 925-940, Cambridge University Press (CUP) [doi]  [abs]
  3. Spanbauer, TL; Fritz, SC; Baker, PA, Punctuated changes in the morphology of an endemic diatom from Lake Titicaca, Paleobiology, vol. 44 no. 1 (February, 2018), pp. 89-100, Cambridge University Press (CUP) [doi]  [abs]
  4. Terborgh, JW; Davenport, LC; Belcon, AU; Katul, G; Swenson, JJ; Fritz, SC; Baker, PA, Twenty-three-year timeline of ecological stable states and regime shifts in upper Amazon oxbow lakes, Hydrobiologia, vol. 807 no. 1 (February, 2018), pp. 99-111, Springer Nature [doi]  [abs]

Bonilla-Silva, Eduardo

  1. Bonilla-Silva, E, Feeling Race: Theorizing the Racial Economy of Emotions, American Sociological Review, vol. 84 no. 1 (February, 2019), pp. 1-25 [doi]  [abs]
  2. Bonilla-Silva, E, “Racists,” “Class Anxieties,” Hegemonic Racism, and Democracy in Trump’s America, Social Currents, vol. 6 no. 1 (February, 2019), pp. 14-31, SAGE Publications [doi]  [abs]

Boyd, David L.

  1. Cai, Y; Boyd, DL, Effect of a traditional Chinese medicine course for undergraduate nursing students: A pre-/post-test study., Nurse Education Today, vol. 70 (November, 2018), pp. 87-93 [doi]  [abs]
  2. Hoyler, E; Martinez, R; Mehta, K; Nisonoff, H; Boyd, D, Beyond medical pluralism: characterising health-care delivery of biomedicine and traditional medicine in rural Guatemala., Global Public Health, vol. 13 no. 4 (April, 2018), pp. 503-517 [doi]  [abs]

Brands, Hal

  1. Brands, H; Inboden, W, Wisdom without tears: Statecraft and the uses of history, Journal of Strategic Studies (January, 2018), pp. 1-31 [doi]  [abs]
  2. Brands, H; Feaver, P, The Case for Reassessing America's 43 rd President, Orbis, vol. 62 no. 1 (2018), pp. 76-90 [doi]  [abs]

Clifford, Joan

  1. Clifford, J; Reisinger, DS, Community-Based Language Learning A Framework for Educators (November, 2018), pp. 208 pages, ISBN 1626166358  [abs]

Dorfman, Ariel

  1. Dorfman, A, Advice for Maduro, Nation, vol. 308 no. 6 (March, 2019), pp. 4-+, NATION CO INC

Dundas, Iara

  1. Dundas, I, Judgment, Resurrection, Conversion: Art in France During the Wars of Religion, in Art and Reform in the Late Renaissance After Trent (February, 2019), pp. 72-92, Routledge, ISBN 0815393881  [abs]

Furtado, Gustavo P.

  1. Furtado, GP, Documentary Filmmaking in Contemporary Brazil Cinematic Archives of the Present (January, 2019), pp. 280 pages, Oxford University Press, USA, ISBN 0190867043  [abs]

Gereffi, Gary

  1. Li, F; Frederick, S; Gereffi, G, E-Commerce and Industrial Upgrading in the Chinese Apparel Value Chain, Journal of Contemporary Asia, vol. 49 no. 1 (January, 2019), pp. 24-53, Informa UK Limited [doi]
  2. Christian, M; Gerreffi, G; Gereffi, G, Fast Food Value Chains and Childhood Obesity: A Global Perspective, in Pediatric Obesity: Etiology, Pathogenesis and Treatment, edited by Freemark, MS (January, 2018), pp. 717-730, Humana Press, , Springer International POublishing, ISBN 978-3-319-68191-7 [doi]
  3. Gereffi, G, Global Value Chains and International Development: Framework, Findings and Policies [published in Chinese] (January, 2018), Shanghai People's Publishing House, ISBN 9787208148369  [abs]
  4. Marchi, VD; Maria, ED; Gereffi, G, Local Clusters in Global Value Chains Linking Actors and Territories Through Manufacturing and Innovation (January, 2018), pp. 230 pages, Routledge, ISBN 1351723995 [doi]  [abs]
  5. De Marchi, V; Di Maria, E; Gereffi, G, Industrial Districts, Clusters and Global Value Chains: Toward in Integrated Framework, in Local Clusters in Global Value Chains: Linking Actors and Territories through Manufacturing and Innovation, edited by De Marchi, V; Di Maria, E; Gereffi, G (January, 2018), pp. 1-18, Routledge, ISBN 978-1-138-74286-4
  6. De Marchi, V; Gereffi, G; Grandinetti, R, Evolutionary Trajectories of Industrial Districts in Global Value Chains, in Local Clusters in Global Value Chains: Linking Actors and Territories through Manufacturing and Innovation., edited by De Marchi, V; Di Maria, E; Gereffi, G (January, 2018), pp. 33-50, Routledge, ISBN 978-1-138-74286-4
  7. De Marchi, V; Di Maria, E; Gereffi, G, New Frontiers for Competitiveness and Innovation in Cluster and Value-Chain Research, in Local Clusters in Global Value Chains: Linking Actors and Territories through Manufacturing and Innovation, edited by De Marchi, V; Di Maria, E; Gereffi, G (January, 2018), pp. 213-225, Routledge, ISBN 9781138742864

Helfer, Laurence R.

  1. Helfer, L; Alter, K; Hafner-Burton, E, Theorizing the Judicialization of International Relations, International Studies Quarterly (2019)
  2. Helfer, L, Populism and International Human Rights Institutions: A Survival Guide (2019)
  3. Helfer, L, Treaty Exit and Intra-Branch Conflict at the Interface of International and Domestic Law (2019)
  4. Helfer, L; Alter, K; Madsen, M, International Court Authority (2018), Oxford University Press
  5. Helfer, L; Alter, K; Madsen, M, How Context Shapes the Authority of International Courts, in International Court Authority (2018), pp. 24-56, Oxford University Press
  6. Helfer, L, The Authority of the Andean Tribunal of Justice within a Diminishing Regional Integration Project, in International Court Authority (2018), Oxford University Press
  7. Helfer, L, Human Rights and Intellectual Property: Mapping an Evolving and Contested Relationship, in Oxford Handbook of Intellectual Property Law (2018), pp. 117
  8. Helfer, L; Alter, K; Madsen, M, International Court Authority in a Complex World, in International Court Authority (2018), pp. 3-23, Oxford University Press
  9. Helfer, L; Alter, K, The Andean Tribunal of Justice: From Washington Consensus to Regional Crisis, in International Court Authority (2018), pp. 173-195, Oxford University Press
  10. Helfer, L; Alter, K; Madsen, M, International Court Authority in Question: Introduction to Part III, in International Court Authority (2018), pp. 365-373, Oxford University Press
  11. Helfer, L; Alter, K; Madsen, M, Conclusion: Context, Authority, Power, in International Court Authority (2018), pp. 435-460, Oxford University Press

Kelly, Stephen

  1. Kelly, S, At the U.S.-Mexico border, avoiding a water war, The Houston Chronicle (June, 2018)  [abs]
  2. Kelly, S, Will America Lose Canada?, The New York times on the Web (June, 2018), New York Times Company  [abs]

Lopes, Renato D.

  1. Machline-Carrion, MJ; Santucci, EV; Damiani, LP; Bahit, MC; Málaga, G; Pontes-Neto, OM; Martins, SCO; Zétola, VF; Normilio-Silva, K; Rodrigues de Freitas, G; Gorgulho, A; De Salles, A; Pacheco da Silva, BG; Santos, JY; de Andrade Jesuíno, I; Bueno, PRT; Cavalcanti, AB; Guimarães, HP; Xian, Y; Bettger, JP; Lopes, RD; Peterson, ED; Berwanger, O; BRIDGE-Stroke Investigators,, Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial., Jama Neurology (May, 2019) [doi]  [abs]
  2. Spitzer, E; McFadden, E; Vranckx, P; Garcia-Garcia, HM; Seltzer, JH; Held, C; de Vries, T; Menon, V; Brown, KJ; Soliman, OII; Onuma, Y; Lopes, RD; Stone, GW; Cutlip, DE; Serruys, PW, Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document., Jacc. Cardiovascular Interventions, vol. 12 no. 9 (May, 2019), pp. 805-819 [doi]  [abs]
  3. Harskamp, RE; Granger, TM; Clare, RM; White, KR; Lopes, RD; Pieper, KS; Granger, CB; Newgard, CB; Shah, SH; Newby, LK, Peripheral blood metabolite profiles associated with new onset atrial fibrillation., American Heart Journal, vol. 211 (May, 2019), pp. 54-59 [doi]  [abs]
  4. Guimarães, PO; Peterson, ED; Stevens, SR; Lokhnygina, Y; Green, JB; McGuire, DK; Holman, RR; Lopes, RD, Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes., International Journal of Cardiology (April, 2019) [doi]  [abs]
  5. Guimarães, PO; Lopes, RD; Alexander, JH; Thomas, L; Hellkamp, AS; Hijazi, Z; Hylek, EM; Gersh, BJ; Garcia, DA; Verheugt, FWA; Hanna, M; Flaker, G; Vinereanu, D; Granger, CB, International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin., Journal of Thrombosis and Thrombolysis (April, 2019) [doi]  [abs]
  6. Machline-Carrion, MJ; Soares, RM; Damiani, LP; Campos, VB; Sampaio, B; Fonseca, FH; Izar, MC; Amodeo, C; Pontes-Neto, OM; Santos, JY; Gomes, SPDC; Saraiva, JFK; Ramacciotti, E; Barros E Silva, PGDM; Lopes, RD; Brandão da Silva, N; Guimarães, HP; Piegas, L; Stein, AT; Berwanger, O; BRIDGE Cardiovascular Prevention Investigators,, Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial., Jama Cardiology (April, 2019) [doi]  [abs]
  7. Lopes, RD; Heizer, G; Aronson, R; Vora, AN; Massaro, T; Mehran, R; Goodman, SG; Windecker, S; Darius, H; Li, J; Averkov, O; Bahit, MC; Berwanger, O; Budaj, A; Hijazi, Z; Parkhomenko, A; Sinnaeve, P; Storey, RF; Thiele, H; Vinereanu, D; Granger, CB; Alexander, JH; AUGUSTUS Investigators,, Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation., The New England Journal of Medicine, vol. 380 no. 16 (April, 2019), pp. 1509-1524 [doi]  [abs]
  8. Washam, JB; Hohnloser, SH; Lopes, RD; Wojdyla, DM; Vinereanu, D; Alexander, JH; Gersh, BJ; Hanna, M; Horowitz, J; Hylek, EM; Xavier, D; Verheugt, FWA; Wallentin, L; Granger, CB; ARISTOTLE Committees and Investigators,, Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial., Journal of Thrombosis and Thrombolysis, vol. 47 no. 3 (April, 2019), pp. 345-352 [doi]  [abs]
  9. Guimarães, PO; Pokorney, SD; Lopes, RD; Wojdyla, DM; Gersh, BJ; Giczewska, A; Carnicelli, A; Lewis, BS; Hanna, M; Wallentin, L; Vinereanu, D; Alexander, JH; Granger, CB, Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial., Clinical Cardiology (March, 2019) [doi]  [abs]
  10. Pokorney, SD; Lopes, RD, Atrial fibrillation: what do we know about screening and what do we not know about treatment?, Heart (March, 2019) [doi]
  11. Fanaroff, AC; Califf, RM; Windecker, S; Smith, SC; Lopes, RD, Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018., Jama, vol. 321 no. 11 (March, 2019), pp. 1069-1080 [doi]  [abs]
  12. Hochman, JS; Reynolds, HR; Bangalore, S; O'Brien, SM; Alexander, KP; Senior, R; Boden, WE; Stone, GW; Goodman, SG; Lopes, RD; Lopez-Sendon, J; White, HD; Maggioni, AP; Shaw, LJ; Min, JK; Picard, MH; Berman, DS; Chaitman, BR; Mark, DB; Spertus, JA; Cyr, DD; Bhargava, B; Ruzyllo, W; Wander, GS; Chernyavskiy, AM; Rosenberg, YD; Maron, DJ; ISCHEMIA Research Group,, Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial., Jama Cardiology (February, 2019) [doi]  [abs]
  13. Van der Wall, SJ; Lopes, RD; Aisenberg, J; Reilly, P; van Ryn, J; Glund, S; Elsaesser, A; Klok, FA; Pollack, CV; Huisman, MV, Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding., Circulation, vol. 139 no. 6 (February, 2019), pp. 748-756 [doi]  [abs]
  14. Alexander, KP; Brouwer, MA; Mulder, H; Vinereanu, D; Lopes, RD; Proietti, M; Al-Khatib, SM; Hijazi, Z; Halvorsen, S; Hylek, EM; Verheugt, FWA; Alexander, JH; Wallentin, L; Granger, CB; ARISTOTLE Investigators,, Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial., American Heart Journal, vol. 208 (February, 2019), pp. 123-131 [doi]  [abs]
  15. Fanaroff, AC; Clare, R; Pieper, KS; Mahaffey, KW; Melloni, C; Green, JB; Alexander, JH; Jones, WS; Harrison, RW; Mehta, RH; Povsic, TJ; Moreira, HG; Al-Khatib, SM; Roe, MT; Kong, DF; Mathews, R; Tricoci, P; Holman, RR; Wallentin, L; Held, C; Califf, RM; Alexander, KP; Lopes, RD, Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials., Circulation, vol. 139 no. 7 (February, 2019), pp. 863-873 [doi]  [abs]
  16. Ranney, DN; Williams, JB; Mulder, H; Wojdyla, D; Cox, ML; Gibson, CM; Mack, MJ; Daneshmand, MA; Alexander, JH; Lopes, RD, Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial)., The American Journal of Cardiology, vol. 123 no. 4 (February, 2019), pp. 571-575 [doi]  [abs]
  17. Christersson, C; Wallentin, L; Andersson, U; Alexander, JH; Alings, M; De Caterina, R; Gersh, BJ; Granger, CB; Halvorsen, S; Hanna, M; Huber, K; Hylek, EM; Lopes, RD; Oh, B-H; Siegbahn, A, Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation., Heart, vol. 105 no. 3 (February, 2019), pp. 235-242 [doi]  [abs]
  18. Held, C; White, HD; Stewart, RAH; Davies, R; Sampson, S; Chiswell, K; Silverstein, A; Lopes, RD; Heldestad, U; Budaj, A; Mahaffey, KW; Wallentin, L; STABILITY Investigators,, Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial., American Heart Journal, vol. 208 (February, 2019), pp. 65-73 [doi]  [abs]
  19. Guimarães, PO; Zakroysky, P; Goyal, A; Lopes, RD; Kaltenbach, LA; Wang, TY, Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction., The American Journal of Cardiology, vol. 123 no. 1 (January, 2019), pp. 12-18 [doi]  [abs]
  20. Vamos, M; Erath, JW; Benz, AP; Lopes, RD; Hohnloser, SH, Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update., The American Journal of Cardiology, vol. 123 no. 1 (January, 2019), pp. 69-74 [doi]  [abs]
  21. Machline-Carrion, MJ; Santucci, EV; Damiani, LP; Bahit, C; Málaga, G; Pontes-Neto, OM; Martins, SCO; Zétola, VF; Normilio-Silva, K; de Freitas, GR; Gorgulho, A; De Salles, A; da Silva, BGP; Santos, JY; de Andrade Jesuíno, I; Bueno, PRT; Cavalcanti, AB; Guimarães, HP; Xian, Y; Bettger, JP; Lopes, RD; Peterson, ED; Berwanger, O, An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial., American Heart Journal, vol. 207 (January, 2019), pp. 49-57 [doi]  [abs]
  22. Machline-Carrion, MJ; Soares, RM; Damiani, LP; Campos, VB; Sampaio, B; Yamashita, J; Fonseca, FH; Izar, MC; Amodeo, C; Pontes-Neto, OM; de Melo Barros, PG; Lopes, RD; Brandão da Silva, N; Guimarães, HP; Piegas, L; Stein, AT; Berwanger, O, Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial., American Heart Journal, vol. 207 (January, 2019), pp. 40-48 [doi]  [abs]
  23. Berger, JS; Abramson, BL; Lopes, RD; Heizer, G; Rockhold, FW; Baumgartner, I; Fowkes, FGR; Held, P; Katona, BG; Norgren, L; Jones, WS; Millegård, M; Blomster, J; Reist, C; Hiatt, WR; Patel, MR; Mahaffey, KW, Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial., Vascular Medicine, vol. 23 no. 6 (December, 2018), pp. 523-530 [doi]  [abs]
  24. Low Wang, CC; Blomster, JI; Heizer, G; Berger, JS; Baumgartner, I; Fowkes, FGR; Held, P; Katona, BG; Norgren, L; Jones, WS; Lopes, RD; Olin, JW; Rockhold, FW; Mahaffey, KW; Patel, MR; Hiatt, WR; EUCLID Trial Executive Committee and Investigators,, Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial., Journal of the American College of Cardiology, vol. 72 no. 25 (December, 2018), pp. 3274-3284, Elsevier BV [doi]  [abs]
  25. Fanaroff, AC; Cyr, D; Neely, ML; Bakal, J; White, HD; Fox, KAA; Armstrong, PW; Lopes, RD; Ohman, EM; Roe, MT, Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes., Circulation. Cardiovascular Quality and Outcomes, vol. 11 no. 12 (December, 2018), pp. e004755 [doi]  [abs]
  26. Olivier, CB; Sundaram, V; Bhatt, DL; Leonardi, S; Lopes, RD; Ding, VY; Yang, L; Stone, GW; Steg, PG; Gibson, CM; Hamm, CW; Price, MJ; White, HD; Desai, M; Lynch, DR; Harrington, RA; Mahaffey, KW; CHAMPION PLATFORM and CHAMPION PCI Investigators,, Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials., International Journal of Cardiology, vol. 270 (November, 2018), pp. 96-101 [doi]  [abs]
  27. Sawhney, JP; Kothiwale, VA; Bisne, V; Durgaprasad, R; Jadhav, P; Chopda, M; Vanajakshamma, V; Meena, R; Vijayaraghavan, G; Chawla, K; Allu, J; Pieper, KS; John Camm, A; Kakkar, AK; GARFIELD-AF Investigators,, Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry., Indian Heart Journal, vol. 70 no. 6 (November, 2018), pp. 828-835, Elsevier BV [doi]  [abs]
  28. Lopes, RD; de Barros E Silva, PGM; de Andrade Jesuíno, I; Santucci, EV; Barbosa, LM; Damiani, LP; Nakagawa Santos, RH; Laranjeira, LN; Dall Orto, FTC; Beraldo de Andrade, P; de Castro Bienert, IR; Alexander, JH; Granger, CB; Berwanger, O, Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial., Jama Cardiology, vol. 3 no. 11 (November, 2018), pp. 1113-1118 [doi]  [abs]
  29. Hernandez, AF; Green, JB; Janmohamed, S; D'Agostino, RB; Granger, CB; Jones, NP; Leiter, LA; Rosenberg, AE; Sigmon, KN; Somerville, MC; Thorpe, KM; McMurray, JJV; Del Prato, S; Harmony Outcomes committees and investigators,, Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial., Lancet (London, England), vol. 392 no. 10157 (October, 2018), pp. 1519-1529 [doi]  [abs]
  30. Nicolau, JC; Furtado, RHM; Baracioli, LM; Lara, LM; Dalçóquio, TF; Scanavini Junior, MA; Pereira, CAC; Lima, VM; Gonçalves, TM; Colodetti, R; Ferrari, AG; Lopes, RD; Giugliano, RP, The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study., Cardiovascular Drugs and Therapy, vol. 32 no. 5 (October, 2018), pp. 435-442 [doi]  [abs]
  31. Sharma, A; Hijazi, Z; Andersson, U; Al-Khatib, SM; Lopes, RD; Alexander, JH; Held, C; Hylek, EM; Leonardi, S; Hanna, M; Ezekowitz, JA; Siegbahn, A; Granger, CB; Wallentin, L, Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation., Circulation, vol. 138 no. 16 (October, 2018), pp. 1666-1676 [doi]  [abs]
  32. Luo, N; Xu, H; Jneid, H; Fonarow, GC; Lopes, RD; Piccini, JP; Curtis, AB; Russo, AM; Lewis, WR; Matsouaka, RA; Granger, CB; Mentz, RJ; Al-Khatib, SM, Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation., Circulation. Heart Failure, vol. 11 no. 10 (October, 2018), pp. e005356 [doi]  [abs]
  33. Mentz, RJ; Bethel, MA; Merrill, P; Lokhnygina, Y; Buse, JB; Chan, JC; Felício, JS; Goodman, SG; Choi, J; Gustavson, SM; Iqbal, N; Lopes, RD; Maggioni, AP; Öhman, P; Pagidipati, NJ; Poulter, NR; Ramachandran, A; Reicher, B; Holman, RR; Hernandez, AF; EXSCEL Study Group,, Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial., Journal of the American Heart Association, vol. 7 no. 19 (October, 2018), pp. e009304 [doi]  [abs]
  34. Nazha, B; Pandya, B; Cohen, J; Zhang, M; Lopes, RD; Garcia, DA; Sherwood, MW; Spyropoulos, AC, Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation., Circulation, vol. 138 no. 14 (October, 2018), pp. 1402-1411 [doi]  [abs]
  35. Lopes, RD; Steffel, J; Di Fusco, M; Keshishian, A; Luo, X; Li, X; Masseria, C; Hamilton, M; Friend, K; Gupta, K; Mardekian, J; Pan, X; Baser, O; Jones, WS, Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease., The American Journal of Medicine, vol. 131 no. 9 (September, 2018), pp. 1075-1085.e4 [doi]  [abs]
  36. Spyropoulos, AC; Ageno, W; Albers, GW; Elliott, CG; Halperin, JL; Hiatt, WR; Maynard, GA; Steg, PG; Weitz, JI; Suh, E; Spiro, TE; Barnathan, ES; Raskob, GE; MARINER Investigators,, Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness., The New England Journal of Medicine, vol. 379 no. 12 (September, 2018), pp. 1118-1127 [doi]  [abs]
  37. de Barros E Silva, PGM; Ribeiro, HB; Lopes, RD; Macedo, TA; Conejo, F; do Amaral Baruzzi, AC; Okada, MY; Garcia, JCT; Rodrigues, MJ; Furlan, V; Ribeiro, EE, Improvement in quality indicators using NCDR® registries: First international experience., International Journal of Cardiology, vol. 267 (September, 2018), pp. 13-15 [doi]  [abs]
  38. Vora, AN; Dai, D; Matsuoka, R; Harrison, JK; Hughes, GC; Sherwood, MW; Piccini, JP; Bhardwaj, B; Lopes, RD; Cohen, D; Holmes, DR; Thourani, VH; Peterson, E; Kirtane, A; Kapadia, S; Vemulapalli, S, Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry., Jacc. Cardiovascular Interventions, vol. 11 no. 17 (September, 2018), pp. 1746-1756 [doi]  [abs]
  39. Lopes, RD; Barroso, WKS; Brandao, AA; Barbosa, ECD; Malachias, MVB; Gomes, MM; Amodeo, C; Dos Santos Povoa, RM; Cavalcante, MA; Précoma, DB; Sousa, ACS; Dantas, JMM; Cesarino, EJ; Veiga Jardim, PCB; RBH Investigators,, The First Brazilian Registry of Hypertension., American Heart Journal (August, 2018) [doi]  [abs]
  40. Vinereanu, D; Wang, A; Mulder, H; Lopes, RD; Jansky, P; Lewis, BS; Gersh, BJ; Avezum, A; Hanna, M; Held, C; Wallentin, L; Granger, CB; Alexander, JH, Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease., Heart, vol. 104 no. 15 (August, 2018), pp. 1292-1299 [doi]  [abs]
  41. van Diepen, S; Tran, DT; Ezekowitz, JA; Zygun, DA; Katz, JN; Lopes, RD; Newby, LK; McAlister, FA; Kaul, P, The high cost of critical care unit over-utilization for patients with NSTE ACS., American Heart Journal, vol. 202 (August, 2018), pp. 84-88 [doi]  [abs]
  42. Capodanno, D; Mehran, R; Valgimigli, M; Baber, U; Windecker, S; Vranckx, P; Dangas, G; Rollini, F; Kimura, T; Collet, J-P; Gibson, CM; Steg, PG; Lopes, RD; Gwon, H-C; Storey, RF; Franchi, F; Bhatt, DL; Serruys, PW; Angiolillo, DJ, Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention., Nature Reviews. Cardiology, vol. 15 no. 8 (August, 2018), pp. 480-496 [doi]  [abs]
  43. Berwanger, O; Nicolau, JC; Carvalho, AC; Jiang, L; Goodman, S; Nicholls, SJ; Parkhomenko, A; Averkov, O; Tajer, C; Malaga, G; Kerr Saraiva, JF; Fonseca, F; Guimaraes, HP; de Barros E Silva, PGM; Damiani, LP; Paisani, DM; Lasagno, CMR; Candido, CT; Valeis, N; Moia, DDF; Piegas, LS; Granger, CB; White, H; Lopes, RD, Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial., American Heart Journal, vol. 202 (August, 2018), pp. 89-96, Elsevier BV [doi]  [abs]
  44. Fanaroff, AC; Steffel, J; Alexander, JH; Lip, GYH; Califf, RM; Lopes, RD, Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe., European Heart Journal, vol. 39 no. 32 (August, 2018), pp. 2932-2941 [doi]  [abs]
  45. Horowitz, JD; De Caterina, R; Heresztyn, T; Alexander, JH; Andersson, U; Lopes, RD; Steg, PG; Hylek, EM; Mohan, P; Hanna, M; Jansky, P; Granger, CB; Wallentin, L; ARISTOTLE Investigators,, Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy., Journal of the American College of Cardiology, vol. 72 no. 7 (August, 2018), pp. 721-733 [doi]  [abs]
  46. Filgueiras Filho, NM; Feitosa Filho, GS; Solla, DJF; Argôlo, FC; Guimarães, PO; Paiva Filho, IDM; Carvalho, LGM; Teixeira, LS; Rios, MNDO; Câmara, SF; Novais, VO; Barbosa, LDS; Ballalai, CS; De Lúcia, CV; Granger, CB; Newby, LK; Lopes, RD, Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST)., Journal of the American Heart Association, vol. 7 no. 14 (July, 2018) [doi]  [abs]
  47. Lopes, RD; Rordorf, R; De Ferrari, GM; Leonardi, S; Wallentin, L, Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed., Journal of the American College of Cardiology, vol. 72 no. 1 (July, 2018), pp. 125-126 [doi]
  48. Inohara, T; Pieper, K; Wojdyla, DM; Patel, MR; Jones, WS; Tricoci, P; Mahaffey, KW; James, SK; Alexander, JH; Lopes, RD; Wallentin, L; Ohman, EM; Roe, MT; Vemulapalli, S, Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome., American Heart Journal, vol. 201 (July, 2018), pp. 25-32 [doi]  [abs]
  49. Lehman, EP; Cowper, PA; Randolph, TC; Kosinski, AS; Lopes, RD; Douglas, PS, Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction., The American Journal of Cardiology, vol. 122 no. 1 (July, 2018), pp. 121-128 [doi]  [abs]
  50. Rymer, JA; Tempelhof, MW; Clare, RM; Pieper, KS; Granger, CB; Van de Werf, F; Moliterno, DJ; Harrington, RA; White, HD; Armstrong, PW; Lopes, RD; Mahaffey, KW; Newby, LK, Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction., American Heart Journal, vol. 201 (July, 2018), pp. 103-110 [doi]  [abs]
  51. Lopes, RD; Vora, AN; Liaw, D; Granger, CB; Darius, H; Goodman, SG; Mehran, R; Windecker, S; Alexander, JH, An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial., American Heart Journal, vol. 200 (June, 2018), pp. 17-23 [doi]  [abs]
  52. Sposato, LA; Lopes, RD, Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice., International Journal of Cardiology, vol. 261 (June, 2018), pp. 99-100 [doi]
  53. Roever, L; Resende, ES; Diniz, ALD; Penha-Silva, N; O'Connell, JL; Gomes, PFS; Zanetti, HR; Roerver-Borges, AS; Veloso, FC; Souza, FRD; Duarte, PRA; Fidale, TM; Casella-Filho, A; Dourado, PMM; Chagas, ACP; Ali-Hasan-Al-Saegh, S; Reis, PEO; Pinto, RDMC; Oliveira, GBF; Avezum, Á; Neto, M; Durães, AR; Silva, RMFLD; Grande, AJ; Denardi, C; Lopes, RD; Nerlekar, N; Alizadeh, S; Hernandez, AV; Rosa, MID; Biondi-Zoccai, G; Brazilian Network of Research in Meta-analysis (BRAMETIS),, High-density lipoprotein-cholesterol functionality and metabolic syndrome: Protocol for review and meta-analysis., Medicine, vol. 97 no. 24 (June, 2018), pp. e11094 [doi]  [abs]
  54. Berwanger, O; Nicolau, JC; Carvalho, AC; Jiang, L; Goodman, SG; Nicholls, SJ; Parkhomenko, A; Averkov, O; Tajer, C; Malaga, G; Saraiva, JFK; Fonseca, FA; De Luca, FA; Guimaraes, HP; de Barros E Silva, PGM; Damiani, LP; Paisani, DM; Lasagno, CMR; Candido, CT; Valeis, N; Moia, DDF; Piegas, LS; Granger, CB; White, HD; Lopes, RD; TREAT Study Group,, Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial., Jama Cardiology, vol. 3 no. 5 (May, 2018), pp. 391-399 [doi]  [abs]
  55. Wang, A; Wu, A; Wojdyla, D; Lopes, RD; Newby, LK; Newman, MF; Smith, PK; Alexander, JH, Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery., American Heart Journal, vol. 199 (May, 2018), pp. 150-155 [doi]  [abs]
  56. Lopes, RD; Guimarães, PO; Crowther, M; Hylek, E; Feitosa-Filho, GS; Ritt, LE; Filgueiras, N; Garcia, DA, Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil., Journal of Thrombosis and Thrombolysis, vol. 45 no. 4 (May, 2018), pp. 578-587 [doi]  [abs]
  57. Spitzer, E; McFadden, E; Vranckx, P; de Vries, T; Ren, B; Collet, C; Onuma, Y; Garcia-Garcia, HM; Lopes, RD; Stone, GW; Cutlip, DE; Serruys, PW, Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document., Jacc. Cardiovascular Interventions, vol. 11 no. 9 (May, 2018), pp. 823-832 [doi]  [abs]
  58. Goto, S; Merrill, P; Wallentin, L; Wojdyla, DM; Hanna, M; Avezum, A; Easton, JD; Harjola, V-P; Huber, K; Lewis, BS; Parkhomenko, A; Zhu, J; Granger, CB; Lopes, RD; Alexander, JH, Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE., European Heart Journal Cardiovascular Pharmacotherapy, vol. 4 no. 2 (April, 2018), pp. 75-81 [doi]  [abs]
  59. Berwanger, O; Santucci, EV; de Barros E Silva, PGM; Jesuíno, IDA; Damiani, LP; Barbosa, LM; Santos, RHN; Laranjeira, LN; Egydio, FDM; Borges de Oliveira, JA; Dall Orto, FTC; Beraldo de Andrade, P; Bienert, IRDC; Bosso, CE; Mangione, JA; Polanczyk, CA; Sousa, AGDMR; Kalil, RAK; Santos, LDM; Sposito, AC; Rech, RL; Sousa, ACS; Baldissera, F; Nascimento, BR; Giraldez, RRCV; Cavalcanti, AB; Pereira, SB; Mattos, LA; Armaganijan, LV; Guimarães, HP; Sousa, JEMR; Alexander, JH; Granger, CB; Lopes, RD; SECURE-PCI Investigators,, Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial., Jama, vol. 319 no. 13 (April, 2018), pp. 1331-1340 [doi]  [abs]
  60. Roever, L; Resende, ES; Diniz, ALD; Penha-Silva, N; O'Connell, JL; Gomes, PFS; Zanetti, HR; Roerver-Borges, AS; Veloso, FC; Fidale, TM; Casella-Filho, A; Dourado, PMM; Chagas, ACP; Ali-Hasan-Al-Saegh, S; Reis, PEO; Pinto, RDM; Oliveira, GBF; Avezum, Á; Neto, M; Durães, A; Silva, RMFLD; Grande, AJ; Denardi, C; Lopes, RD; Nerlekar, N; Alizadeh, S; Hernandez, AV; Biondi-Zoccai, G; Brazilian Network of Research in Meta-analysis (BRAMETIS),, Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis., Medicine, vol. 97 no. 15 (April, 2018), pp. e9862 [doi]  [abs]
  61. Roever, L; Resende, ES; Diniz, ALD; Penha-Silva, N; O'Connell, JL; Gomes, PFS; Zanetti, HR; Roerver-Borges, AS; Veloso, FC; Souza, FRD; Duarte, PRA; Fidale, TM; Casella-Filho, A; Dourado, PMM; Chagas, ACP; Ali-Hasan-Al-Saegh, S; Reis, PEO; Pinto, RDMC; Oliveira, GBF; Avezum, Á; Neto, M; Durães, A; Silva, RMFLD; Grande, AJ; Denardi, C; Lopes, RD; Nerlekar, N; Alizadeh, S; Hernandez, AV; Rosa, MID; Biondi-Zoccai, G; Brazilian Network of Research in Meta-analysis (BRAMETIS),, Epicardial adipose tissue and metabolic syndrome: An update protocol for systematic review and meta-analysis., Medicine, vol. 97 no. 16 (April, 2018), pp. e0387 [doi]  [abs]
  62. Roever, L; Resende, ES; Diniz, ALD; Penha-Silva, N; O'Connell, JL; Gomes, PFS; Zanetti, HR; Roerver-Borges, AS; Veloso, FC; Fidale, TM; Casella-Filho, A; Dourado, PMM; Chagas, ACP; Ali-Hasan-Al-Saegh, S; Reis, PEO; Pinto, RDM; Oliveira, GBF; Avezum, Á; Neto, M; Durães, A; Silva, RMFLD; Grande, AJ; Denardi, C; Lopes, RD; Nerlekar, N; Alizadeh, S; Hernandez, AV; Biondi-Zoccai, G; Brazilian Network of Research in Meta-analysis (BRAMETIS),, Statins in adult patients with HIV: Protocol for a systematic review and network meta-analysis., Medicine, vol. 97 no. 15 (April, 2018), pp. e0116 [doi]  [abs]
  63. Roever, L; Resende, ES; Diniz, ALD; Penha-Silva, N; O'Connell, JL; Gomes, PFS; Zanetti, HR; Roerver-Borges, AS; Veloso, FC; de Souza, FR; Duarte, PRA; Fidale, TM; Casella-Filho, A; Dourado, PMM; Chagas, ACP; Ali-Hasan-Al-Saegh, S; Reis, PEO; Pinto, RDMC; Oliveira, GBF; Avezum, Á; Neto, M; Durães, A; Silva, RMFLD; Grande, AJ; Denardi, C; Lopes, RD; Nerlekar, N; Alizadeh, S; Hernandez, AV; Rosa, MID; Biondi-Zoccai, G; Brazilian Network of Research in Meta-analysis (BRAMETIS),, Epicardial adipose tissue and carotid artery disease: Protocol for systematic review and meta-analysis., Medicine, vol. 97 no. 17 (April, 2018), pp. e0273 [doi]  [abs]
  64. Berwanger, O; de Barros E Silva, PGM; Dall Orto, FTC; de Andrade, PB; de Castro Bienert, IR; Bosso, CE; Mangione, J; Polanczyk, CA; Sousa, A; Kalil, R; de Moura Santos, L; Sposito, AC; Rech, RL; Sousa, ACS; Baldissera, F; Nascimento, BR; de Andrade Jesuíno, I; Santucci, EV; Damiani, LP; Laranjeira, LN; Borges de Oliveira, JA; Giraldez, RR; Cavalcanti, AB; Pereira, SB; Mattos, LA; Armaganijan, LV; Guimarães, HP; Sousa, JE; Alexander, JH; Granger, CB; Lopes, RD, Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial., American Heart Journal, vol. 198 (April, 2018), pp. 129-134, Elsevier BV [doi]  [abs]
  65. Paquet, M; Cerasuolo, JO; Thorburn, V; Fridman, S; Alsubaie, R; Lopes, RD; Cipriano, LE; Salamone, P; Melling, CWJ; Khan, AR; Sedeño, L; Fang, J; Drangova, M; Montero-Odasso, M; Mandzia, J; Khaw, AV; Racosta, JM; Paturel, J; Samoilov, L; Stirling, D; Balint, B; Jaremek, V; Koschinsky, ML; Boffa, MB; Summers, K; Ibañez, A; Mrkobrada, M; Saposnik, G; Kimpinski, K; Whitehead, SN; Sposato, LA, Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach., Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association, vol. 27 no. 3 (March, 2018), pp. 606-619 [doi]  [abs]
  66. Chiarito, M; Cao, D; Cannata, F; Godino, C; Lodigiani, C; Ferrante, G; Lopes, RD; Alexander, JH; Reimers, B; Condorelli, G; Stefanini, GG, Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis., Jama Cardiology, vol. 3 no. 3 (March, 2018), pp. 234-241 [doi]  [abs]
  67. Rao, MP; Vinereanu, D; Wojdyla, DM; Alexander, JH; Atar, D; Hylek, EM; Hanna, M; Wallentin, L; Lopes, RD; Gersh, BJ; Granger, CB; Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators,, Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial., The American Journal of Medicine, vol. 131 no. 3 (March, 2018), pp. 269-275.e2 [doi]  [abs]
  68. Kopin, D; Jones, WS; Sherwood, MW; Wojdyla, DM; Wallentin, L; Lewis, BS; Verheugt, FWA; Vinereanu, D; Bahit, MC; Halvorsen, S; Huber, K; Parkhomenko, A; Granger, CB; Lopes, RD; Alexander, JH, Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial., American Heart Journal, vol. 197 (March, 2018), pp. 133-141 [doi]  [abs]
  69. Lopes, RD; Rordorf, R; De Ferrari, GM; Leonardi, S; Thomas, L; Wojdyla, DM; Ridefelt, P; Lawrence, JH; De Caterina, R; Vinereanu, D; Hanna, M; Flaker, G; Al-Khatib, SM; Hohnloser, SH; Alexander, JH; Granger, CB; Wallentin, L; ARISTOTLE Committees and Investigators,, Digoxin and Mortality in Patients With Atrial Fibrillation., Journal of the American College of Cardiology, vol. 71 no. 10 (March, 2018), pp. 1063-1074 [doi]  [abs]
  70. Sherwood, MW; Lopes, RD; Sun, JL; Liaw, D; Harrington, RA; Wallentin, L; Laskowitz, DT; James, SK; Goodman, SG; Darius, H; Lewis, BS; Gibson, CM; Pieper, KS; Alexander, JH, Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial., American Heart Journal, vol. 197 (March, 2018), pp. 1-8 [doi]  [abs]
  71. Sposato, LA; Fridman, S; Whitehead, SN; Lopes, RD, Linking stroke-induced heart injury and neurogenic atrial fibrillation: a hypothesis to be proven., Journal of Electrocardiology (February, 2018) [doi]
  72. Vaduganathan, M; Harrington, RA; Stone, GW; Steg, G; Gibson, CM; Hamm, CW; Price, MJ; Lopes, RD; Leonardi, S; Deliargyris, EN; Prats, J; Mahaffey, KW; White, HD; Bhatt, DL, Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials., Eurointervention, vol. 13 no. 15 (February, 2018), pp. e1841-e1849, Europa Digital & Publishing [doi]  [abs]
  73. Hijazi, Z; Oldgren, J; Lindbäck, J; Alexander, JH; Connolly, SJ; Eikelboom, JW; Ezekowitz, MD; Held, C; Hylek, EM; Lopes, RD; Yusuf, S; Granger, CB; Siegbahn, A; Wallentin, L; ARISTOTLE and RE-LY Investigators,, A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score., European Heart Journal, vol. 39 no. 6 (February, 2018), pp. 477-485 [doi]  [abs]
  74. Pol, T; Held, C; Westerbergh, J; Lindbäck, J; Alexander, JH; Alings, M; Erol, C; Goto, S; Halvorsen, S; Huber, K; Hanna, M; Lopes, RD; Ruzyllo, W; Granger, CB; Hijazi, Z, Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial., Journal of the American Heart Association, vol. 7 no. 3 (February, 2018) [doi]  [abs]
  75. Guimarães, PO; Leonardi, S; Huang, Z; Wallentin, L; de Werf, FV; Aylward, PE; Held, C; Harrington, RA; Moliterno, DJ; Armstrong, PW; White, HD; Alexander, KP; Lopes, RD; Mahaffey, KW; Tricoci, P, Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial., American Heart Journal, vol. 196 (February, 2018), pp. 28-35 [doi]  [abs]
  76. Sposato, LA; Lopes, RD, Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?, European Heart Journal, vol. 39 no. 6 (February, 2018), pp. 461-463 [doi]
  77. Sandhu, RK; Ezekowitz, JA; Hijazi, Z; Westerbergh, J; Aulin, J; Alexander, JH; Granger, CB; Halvorsen, S; Hanna, MS; Lopes, RD; Siegbahn, A; Wallentin, L, Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial., Open Heart, vol. 5 no. 2 (January, 2018), pp. e000908 [doi]  [abs]

Milian, Claudia

  1. Milian, C, Crisis management and the Latinx child, English Language Notes, vol. 56 no. 2 (October, 2018), pp. 8-24 [doi]  [abs]
  2. Milian, C, The mesoamerican corridor, central American transits, and Latina/o becomings, in The Cambridge History of Latina/o American Literature (January, 2018), pp. 674-690, Cambridge University Press, ISBN 9781107183087 [doi]  [abs]

Nelson, Diane M.

  1. Nelson, DM, Low intensities, Current Anthropology (January, 2019) [doi]  [abs]

Nicolelis, Miguel A.

  1. Selfslagh, A; Shokur, S; Campos, DSF; Donati, ARC; Almeida, S; Yamauti, SY; Coelho, DB; Bouri, M; Nicolelis, MAL, Non-invasive, Brain-controlled Functional Electrical Stimulation for Locomotion Rehabilitation in Individuals with Paraplegia., Scientific Reports, vol. 9 no. 1 (May, 2019), pp. 6782 [doi]  [abs]
  2. Yin, A; Tseng, PH; Rajangam, S; Lebedev, MA; Nicolelis, MAL, Place Cell-Like Activity in the Primary Sensorimotor and Premotor Cortex During Monkey Whole-Body Navigation., Scientific Reports, vol. 8 no. 1 (June, 2018), pp. 9184 [doi]  [abs]
  3. Nicolelis, MAL, The human brain, the true creator of everything, cannot be simulated by any turing machine, in Think Tank: Forty Neuroscientists Explore the Biological Roots of Human Experience (April, 2018), pp. 263-269, ISBN 9780300225549
  4. Tseng, P-H; Rajangam, S; Lehew, G; Lebedev, MA; Nicolelis, MAL, Interbrain cortical synchronization encodes multiple aspects of social interactions in monkey pairs., Scientific Reports, vol. 8 no. 1 (March, 2018), pp. 4699 [doi]  [abs]
  5. Shokur, S; Donati, ARC; Campos, DSF; Gitti, C; Bao, G; Fischer, D; Almeida, S; Braga, VAS; Augusto, P; Petty, C; Alho, EJL; Lebedev, M; Song, AW; Nicolelis, MAL, Training with brain-machine interfaces, visuo-tactile feedback and assisted locomotion improves sensorimotor, visceral, and psychological signs in chronic paraplegic patients., Plos One, vol. 13 no. 11 (January, 2018), pp. e0206464 [doi]  [abs]
  6. Wiest, M.C. and Nicolelis, M.A.L., Behavioral detection of tactile stimuli during 7-12 Hz cortical oscillations in awake rats, Nat. Neurosci. (USA), vol. 6 no. 9 , pp. 913 - 14 [nn1107]  [abs]

Olcott, Jocelyn

  1. Olcott, J, Public in a Domestic Sense: Sex Work, Nation-Building, and Class Identification in Modern Europe, American Historical Review, vol. 123 no. 1 (February, 2018), pp. 124-131, Oxford University Press (OUP) [doi]  [abs]

Pan, William K.

  1. Wyatt, L; Permar, SR; Ortiz, E; Berky, A; Woods, CW; Amouou, GF; Itell, H; Hsu-Kim, H; Pan, W, Mercury Exposure and Poor Nutritional Status Reduce Response to Six Expanded Program on Immunization Vaccines in Children: An Observational Cohort Study of Communities Affected by Gold Mining in the Peruvian Amazon., International Journal of Environmental Research and Public Health, vol. 16 no. 4 (February, 2019) [doi]  [abs]
  2. Pizzitutti, F; Mena, CF; Feingold, B; Pan, W, Modeling asymptomatic infections and work-related human circulation as drivers of unstable malaria transmission in low-prevalence areas: a study in the Northern Peruvian Amazon., Acta Tropica (January, 2019) [doi]  [abs]
  3. Pan, WK; Seidman, JC; Ali, A; Hoest, C; Mason, C; Mondal, D; Knobler, SL; Bessong, P; MAL-ED Network Investigators,, Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies., Vaccine, vol. 37 no. 2 (January, 2019), pp. 352-365 [doi]  [abs]
  4. Pizzitutti, F; Pan, W; Feingold, B; Zaitchik, B; Álvarez, CA; Mena, CF, Out of the net: An agent-based model to study human movements influence on local-scale malaria transmission., Plos One, vol. 13 no. 3 (January, 2018), pp. e0193493 [doi]  [abs]

Patino-Echeverri, Dalia

  1. Daraeepour, A; Patino-Echeverri, D; Conejo, AJ, Economic and environmental implications of different approaches to hedge against wind production uncertainty in two-settlement electricity markets: A PJM case study, Energy Economics, vol. 80 (May, 2019), pp. 336-354 [doi]  [abs]
  2. Li, M; Patiño-Echeverri, D; Zhang, J, Policies to promote energy efficiency and air emissions reductions in China's electric power generation sector during the 11th and 12th five-year plan periods: Achievements, remaining challenges, and opportunities, Energy Policy, vol. 125 (February, 2019), pp. 429-444, Elsevier BV [doi]  [abs]
  3. Camilleri, AR; Larrick, RP; Hossain, S; Patino-Echeverri, D, Consumers underestimate the emissions associated with food but are aided by labels, Nature Climate Change, vol. 9 no. 1 (January, 2019), pp. 53-58, Springer Nature [doi]  [abs]
  4. Cornelius, A; Bandyopadhyay, R; Patiño-Echeverri, D, Assessing environmental, economic, and reliability impacts of flexible ramp products in MISO's electricity market, Renewable and Sustainable Energy Reviews, vol. 81 (January, 2018), pp. 2291-2298, Elsevier BV [doi]  [abs]

Pfaff, Alexander

  1. Naidoo, R; Gerkey, D; Hole, D; Pfaff, A; Ellis, AM; Golden, CD; Herrera, D; Johnson, K; Mulligan, M; Ricketts, TH; Fisher, B, Evaluating the impacts of protected areas on human well-being across the developing world., Science Advances, vol. 5 no. 4 (April, 2019), pp. eaav3006 [doi]  [abs]
  2. Fisher, B; Herrera, D; Adams, D; Fox, HE; Gallagher, L; Gerkey, D; Gill, D; Golden, CD; Hole, D; Johnson, K; Mulligan, M; Myers, SS; Naidoo, R; Pfaff, A; Rasolofoson, R; Selig, ER; Tickner, D; Treuer, T; Ricketts, T, Can nature deliver on the sustainable development goals?, The Lancet. Planetary Health, vol. 3 no. 3 (March, 2019), pp. e112-e113 [doi]
  3. Pfaff, A; Rodriguez, LA; Shapiro-Garza, E, Collective Local Payments for ecosystem services: New local PES between groups, sanctions, and prior watershed trust in Mexico, Water Resources and Economics (January, 2019) [doi]  [abs]
  4. Panlasigui, S; Rico-Straffon, J; Pfaff, A; Swenson, J; Loucks, C, Impacts of certification, uncertified concessions, and protected areas on forest loss in Cameroon, 2000 to 2013, Biological Conservation, vol. 227 (November, 2018), pp. 160-166, Elsevier BV [doi]  [abs]
  5. Pfaff, A; Robalino, J; Reis, EJ; Walker, R; Perz, S; Laurance, W; Bohrer, C; Aldrich, S; Arima, E; Caldas, M; Kirby, K, Roads & SDGs, tradeoffs and synergies: Learning from Brazil’s Amazon in distinguishing frontiers, Economics: the Open Access, Open Assessment E Journal, vol. 12 (March, 2018), ZBW - German National Library of Economics [doi]  [abs]
  6. Tesfaw, AT; Pfaff, A; Golden Kroner, RE; Qin, S; Medeiros, R; Mascia, MB, Land-use and land-cover change shape the sustainability and impacts of protected areas., Proceedings of the National Academy of Sciences of the United States of America, vol. 115 no. 9 (February, 2018), pp. 2084-2089 [doi]  [abs]
  7. Pfaff, A; Velez, MA; Broad, K; Hamoudi, A; Taddei, R, Contracts versus trust for transfers of ecosystem services: Equity and efficiency in resource allocation and environmental provision, Water Resources and Economics (January, 2018), Elsevier BV [doi]  [abs]

Pimm, Stuart L.

  1. Tian, Z; Liu, X; Fan, Z; Liu, J; Pimm, SL; Liu, L; Garcia, C; Songer, M; Shao, X; Skidmore, A; Wang, T; Zhang, Y; Chang, Y; Jin, X; Gong, M; Zhou, L; He, X; Dang, G; Zhu, Y; Cai, Q, The next widespread bamboo flowering poses a massive risk to the giant panda, Biological Conservation, vol. 234 (June, 2019), pp. 180-187 [doi]  [abs]
  2. Vijay, V; Reid, CD; Finer, M; Jenkins, CN; Pimm, SL, Deforestation risks posed by oil palm expansion in the Peruvian Amazon, Environmental Research Letters, vol. 13 no. 11 (November, 2018), pp. 114010-114010, IOP Publishing [doi]  [abs]
  3. Carter, NH; Bouley, P; Moore, S; Poulos, M; Bouyer, J; Pimm, SL, Climate change, disease range shifts, and the future of the Africa lion., Conservation Biology : the Journal of the Society for Conservation Biology, vol. 32 no. 5 (October, 2018), pp. 1207-1210 [doi]
  4. Gagné, TO; Hyrenbach, KD; Hagemann, ME; Bass, OL; Pimm, SL; MacDonald, M; Peck, B; Van Houtan, KS, Seabird trophic position across three ocean regions tracks ecosystem differences, Frontiers in Marine Science, vol. 5 no. SEP (September, 2018), FRONTIERS MEDIA SA [doi]  [abs]
  5. Pimm, SL; Jenkins, CN; Li, BV, How to protect half of Earth to ensure it protects sufficient biodiversity., Science Advances, vol. 4 no. 8 (August, 2018), pp. eaat2616 [doi]  [abs]
  6. Montoya, JM; Donohue, I; Pimm, SL, Why a Planetary Boundary, If It Is Not Planetary, and the Boundary Is Undefined? A Reply to Rockström et al., Trends in Ecology and Evolution, vol. 33 no. 4 (April, 2018), pp. 234 [doi]
  7. Montoya, JM; Donohue, I; Pimm, SL, Planetary Boundaries for Biodiversity: Implausible Science, Pernicious Policies., Trends in Ecology and Evolution, vol. 33 no. 2 (February, 2018), pp. 71-73 [doi]  [abs]
  8. Joppa, Lucas N. and Loarie, Scott R. and Pimm, Stuart L., On the protection of ``protected areas{''}, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 105 no. 18 (2008), pp. 6673-6678, ISSN 0027-8424  [abs]
  9. Vale, Mariana M. and Alves, Maria Alice and Pimm, Stuart L., Biopiracy: conservationists have to rebuild lost trust, NATURE, vol. 453 no. 7191 (2008), pp. 26, ISSN 0028-0836
  10. Pimm, Stuart L., Biodiversity: Climate change or habitat loss - Which will kill more species?, CURRENT BIOLOGY, vol. 18 no. 3 (2008), pp. R117-R119, ISSN 0960-9822  [abs]
  11. Montoya, Jose M. and Pimm, Stuart L. and Sole, Ricard V., Ecological networks and their fragility, NATURE, vol. 442 no. 7100 (2006), pp. 259-264, ISSN 0028-0836  [abs]
  12. Pimm, SL and Brown, JH, Domains of diversity, SCIENCE, vol. 304 no. 5672 (2004), pp. 831-833, ISSN 0036-8075
  13. Ferraz, G and Russell, GJ and Stouffer, PC and Bierregaard, RO and Pimm, SL and Lovejoy, TE, Rates of species loss from Amazonian forest fragments, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 100 no. 24 (2003), pp. 14069-14073, ISSN 0027-8424  [abs]
  14. Sugihara, G and Bersier, LF and Southwood, TRE and Pimm, SL and May, RM, Predicted correspondence between species abundances and dendrograms of niche similarities, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 100 no. 9 (2003), pp. 5246-5251, ISSN 0027-8424  [abs]
  15. Liu, JG and Ouyang, ZY and Pimm, SL and Raven, PH and Wang, XK and Miao, H and Han, NY, Protecting China's biodiversity, SCIENCE, vol. 300 no. 5623 (2003), pp. 1240-1241, ISSN 0036-8075
  16. Pimm, SL and van Aarde, RJ, Population control - African elephants and contraception, NATURE, vol. 411 no. 6839 (2001), pp. 766, ISSN 0028-0836

Rangel, Marcos A.

  1. Rangel, MA; Shi, Y, Early patterns of skill acquisition and immigrants' specialization in STEM careers., Proceedings of the National Academy of Sciences of the United States of America, vol. 116 no. 2 (January, 2019), pp. 484-489 [doi]  [abs]

Rego, Marcia

  1. Rego, M, Unadvisable, Anthropology and Humanism, vol. 43 no. 1 (June, 2018), pp. 156-156, WILEY [doi]

Remmer, Karen L.

  1. Minhas, S; Remmer, KL, The Reputational Impact of Investor-State Disputes, International Interactions, vol. 44 no. 5 (September, 2018), pp. 862-887, Informa UK Limited [doi]  [abs]
  2. K.L. Remmer, The Outcomes of Investment Treaty Arbitration: A Reassessment, in Yearbook of International Law and Policy 2015-16, edited by Lisa Sachs and Lise Johnson (2018), pp. 144-172, New York: Oxford University Press
  3. K.L. Remmer, Investment Treaty Arbitration in Latin America.", Latin American Research Review, vol. 54 no. 4 (2018) (forthcoming.)

Rodríguez García, José María

  1. José Mª Rodríguez García, La bibliofarmacia de Kate Chopin o la lectura como intoxicación, Cuadernos de Investigación Filológica, vol. 29-30 (2003-2004), pp. 7-28

Rosa, Richard

  1. Rosa, R, Finance and Literature in 19th Century Latin America (2019)

Shapiro - Garza, Elizabeth

  1. Van Hecken, G; Kolinjivadi, V; Windey, C; McElwee, P; Shapiro-Garza, E; Huybrechs, F; Bastiaensen, J, Silencing Agency in Payments for Ecosystem Services (PES) by Essentializing a Neoliberal ‘Monster’ Into Being: A Response to Fletcher & Büscher's ‘PES Conceit’, Ecological Economics, vol. 144 (February, 2018), pp. 314-318, Elsevier BV [doi]  [abs]
  2. Osborne, T; Shapiro-Garza, E, Embedding Carbon Markets: Complicating Commodification of Ecosystem Services in Mexico's Forests, Annals of the American Association of Geographers, vol. 108 no. 1 (January, 2018), pp. 88-105, Informa UK Limited [doi]  [abs]
  3. E.N. Shapiro, Community Forum of the Ecosystem Marketplace, Vol. 1, No. 4 & 5; Vol. 2, No. 1-9; Vol. 3 No. 1, www.EcosystemMarketplace.com

Starn, Orin

  1. Starn, O; Serna, ML, The Shining Path Love, Madness, and Revolution in the Andes (2019), pp. 384 pages, W.W. Norton, ISBN 0393292800  [abs]

Swenson, Jennifer J.

  1. Panlasigui, S; Rico-Straffon, J; Pfaff, A; Swenson, J; Loucks, C, Impacts of certification, uncertified concessions, and protected areas on forest loss in Cameroon, 2000 to 2013, Biological Conservation, vol. 227 (November, 2018), pp. 160-166, Elsevier BV [doi]  [abs]
  2. Schwantes, AM; Parolari, AJ; Swenson, JJ; Johnson, DM; Domec, J-C; Jackson, RB; Pelak, N; Porporato, A, Accounting for landscape heterogeneity improves spatial predictions of tree vulnerability to drought., The New Phytologist, vol. 220 no. 1 (October, 2018), pp. 132-146 [doi]  [abs]
  3. Schaffer-Smith, D; Swenson, JJ; Reiter, ME; Isola, JE, Quantifying shorebird habitat in managed wetlands by modeling shallow water depth dynamics., Ecological Applications : a Publication of the Ecological Society of America, vol. 28 no. 6 (September, 2018), pp. 1534-1545 [doi]  [abs]
  4. Gray, PC; Ridge, JT; Poulin, SK; Seymour, AC; Schwantes, AM; Swenson, JJ; Johnston, DW, Integrating drone imagery into high resolution satellite remote sensing assessments of estuarine environments, Remote Sensing, vol. 10 no. 8 (August, 2018), pp. 1257-1257, MDPI AG [doi]  [abs]
  5. Seyednasrollah, B; Jennifer J. Swenson, ; Jean-Christophe Domec, ; James S. Clark,, Leaf phenology paradox: Why warming matters most where it is already warm, Remote Sensing of Environment, vol. 209 (May, 2018), pp. 446-455, Elsevier BV [doi]  [abs]
  6. Johnson, DM; Domec, J-C; Carter Berry, Z; Schwantes, AM; McCulloh, KA; Woodruff, DR; Wayne Polley, H; Wortemann, R; Swenson, JJ; Scott Mackay, D; McDowell, NG; Jackson, RB, Co-occurring woody species have diverse hydraulic strategies and mortality rates during an extreme drought., Plant, Cell & Environment, vol. 41 no. 3 (March, 2018), pp. 576-588 [doi]  [abs]
  7. Terborgh, JW; Davenport, LC; Belcon, AU; Katul, G; Swenson, JJ; Fritz, SC; Baker, PA, Twenty-three-year timeline of ecological stable states and regime shifts in upper Amazon oxbow lakes, Hydrobiologia, vol. 807 no. 1 (February, 2018), pp. 99-111, Springer Nature [doi]  [abs]

Duke University * Arts & Sciences * CLACS * Center director * Center Staff * Council Members * Visiting Scholars * Grad & Professional * Reload * Login